Company / Accounts Receivable
Becton Dickinson Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$3.0B
FY2025
5-year range
$2.2B / $3.0B
FY2021-FY2025
Trend
-1.3%
vs FY2024
Sector context
#10 of 138
Health Care
What the data says
Among 138 Health Care companies, Becton Dickinson is in the top 7% for accounts receivable. Accounts Receivable has fluctuated over the past 10 years, ranging from $1.6B in FY2016 to $3.0B in FY2024.
Based on SEC 10-K filings.
$3.0B in FY2025 with a 5-year CAGR of +4.5%. Top quartile in the Health Care sector.
Improved from $2.5B to $3.0B over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +11.0%
- 5-Year CAGR
- +4.5%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 138This company $3.0B Sector average $1.3B
▼
+126.7% above sector average
Key checks
Key Insights
- 5-year CAGR of +4.5%, indicating consistent growth.
- In FY2025, accounts receivable decreased 1.3% year-over-year.
- Ranks #10 out of 138 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.16 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.0B | -1.3% |
| FY2024 | $3.0B | +19.7% |
| FY2023 | $2.5B | +15.7% |
| FY2022 | $2.2B | -6.8% |
| FY2021 | $2.4B | -2.0% |
| FY2020 | $2.4B | +2.3% |
| FY2019 | $2.3B | +1.1% |
| FY2018 | $2.3B | +33.0% |
| FY2017 | $1.7B | +7.8% |
| FY2016 | $1.6B | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026